Membrane Vesicles for Nanoencapsulated Sulforaphane Increased Their Anti-Inflammatory Role on an In Vitro Human...

Area of Science:

• Plant biotechnology
• Pharmacology
• Immunology

Background:

• Inflammation is a key factor in many diseases, necessitating novel non-toxic anti-inflammatory drugs.
• Sulforaphane (SFN), a plant-derived compound, shows anti-inflammatory potential but suffers from poor stability and bioavailability.
• Nanocarriers offer a solution to improve SFN's stability and delivery.

Purpose of the Study:

• To investigate the anti-inflammatory potential of SFN-loaded broccoli membrane vesicles.
• To evaluate SFN release kinetics from these nanocarriers.
• To assess the anti-inflammatory effects in a human macrophage model.

Main Methods:

• In vitro modeling of SFN release from broccoli membrane vesicles.
• Utilizing a human-macrophage-like cell model under normal and inflammatory conditions.
• Quantifying the levels of key inflammatory cytokines (TNF-α, IL-1β, IL-6).

Main Results:

• Two distinct SFN release phases from membrane vesicles were identified: one rapid and one sustained.
• SFN-loaded vesicles significantly reduced inflammatory markers, including TNF-α, IL-1β, and IL-6.
• Broccoli membrane vesicles alone demonstrated inherent anti-inflammatory activity.

Conclusions:

• Broccoli-derived membrane vesicles are effective carriers for SFN, enhancing its anti-inflammatory action.
• The vesicles themselves possess anti-inflammatory properties, opening new therapeutic avenues.
• This study highlights a dual-action therapeutic strategy using SFN-loaded vesicles.